M D Barber

Summary

Publications

  1. ncbi request reprint Cancer cachexia and its treatment with fish-oil-enriched nutritional supplementation
    M D Barber
    University Department of Surgery, Royal Infirmary of Edinburgh, Edinburgh, Scotland, UK
    Nutrition 17:751-5. 2001
  2. ncbi request reprint Assessment of faecal occult blood loss by qualitative and quantitative methods
    M D Barber
    Department of Surgery, St John s Hospital, Livinsgton, Scotland, U K
    J R Coll Surg Edinb 47:491-4. 2002
  3. pmc The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer
    M D Barber
    University Department of Surgery, Royal Infirmary of Edinburgh, UK
    Br J Cancer 81:80-6. 1999
  4. ncbi request reprint Effect of a fish oil-enriched nutritional supplement on metabolic mediators in patients with pancreatic cancer cachexia
    M D Barber
    University Department of Surgery, Royal Infirmary of Edinburgh, Edinburgh EH3 9YW, UK
    Nutr Cancer 40:118-24. 2001
  5. ncbi request reprint Tolerance and incorporation of a high-dose eicosapentaenoic acid diester emulsion by patients with pancreatic cancer cachexia
    M D Barber
    University Department of Surgery, Royal Infirmary of Edinburgh, Scotland, United Kingdom
    Lipids 36:347-51. 2001
  6. pmc Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial
    K C H Fearon
    Royal Infirmary of Edinburgh, Edinburgh, UK
    Gut 52:1479-86. 2003
  7. pmc The response of leptin, interleukin-6 and fat oxidation to feeding in weight-losing patients with pancreatic cancer
    M D Barber
    University Department of Surgery, Royal Infirmary, Edinburgh EH3 9YW, UK
    Br J Cancer 90:1129-32. 2004
  8. doi request reprint The mammalian target of rapamycin inhibitor everolimus (RAD001) in early breast cancer: results of a pre-operative study
    E J Macaskill
    Western General Hospital, Edinburgh, EH4 2XU, UK
    Breast Cancer Res Treat 128:725-34. 2011
  9. pmc A polymorphism of the interleukin-1 beta gene influences survival in pancreatic cancer
    M D Barber
    University Department of Surgery, Royal Infirmary of Edinburgh, Edinburgh, EH3 9YW, Scotland, UK
    Br J Cancer 83:1443-7. 2000

Collaborators

Detail Information

Publications9

  1. ncbi request reprint Cancer cachexia and its treatment with fish-oil-enriched nutritional supplementation
    M D Barber
    University Department of Surgery, Royal Infirmary of Edinburgh, Edinburgh, Scotland, UK
    Nutrition 17:751-5. 2001
    ..Cachexia is a common condition affecting those with advanced cancer. This review explores mechanisms of cachexia and possible treatments devised with these mechanisms in mind...
  2. ncbi request reprint Assessment of faecal occult blood loss by qualitative and quantitative methods
    M D Barber
    Department of Surgery, St John s Hospital, Livinsgton, Scotland, U K
    J R Coll Surg Edinb 47:491-4. 2002
    ..Various methods exist for the assessment of faecal occult blood loss in a patient with suspected gastrointestinal blood loss...
  3. pmc The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer
    M D Barber
    University Department of Surgery, Royal Infirmary of Edinburgh, UK
    Br J Cancer 81:80-6. 1999
    ..In contrast to previous studies of oral conventional nutritional supplements in weight-losing cancer patients, this study suggests that an EPA-enriched supplement may reverse cachexia in advanced pancreatic cancer...
  4. ncbi request reprint Effect of a fish oil-enriched nutritional supplement on metabolic mediators in patients with pancreatic cancer cachexia
    M D Barber
    University Department of Surgery, Royal Infirmary of Edinburgh, Edinburgh EH3 9YW, UK
    Nutr Cancer 40:118-24. 2001
    ..This may account for the reversal of weight loss in patients consuming this supplement...
  5. ncbi request reprint Tolerance and incorporation of a high-dose eicosapentaenoic acid diester emulsion by patients with pancreatic cancer cachexia
    M D Barber
    University Department of Surgery, Royal Infirmary of Edinburgh, Scotland, United Kingdom
    Lipids 36:347-51. 2001
    ..The acceptibility of large doses of oral EPA should allow larger controlled clinical studies into potential anticancer effects of EPA...
  6. pmc Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial
    K C H Fearon
    Royal Infirmary of Edinburgh, Edinburgh, UK
    Gut 52:1479-86. 2003
    ....
  7. pmc The response of leptin, interleukin-6 and fat oxidation to feeding in weight-losing patients with pancreatic cancer
    M D Barber
    University Department of Surgery, Royal Infirmary, Edinburgh EH3 9YW, UK
    Br J Cancer 90:1129-32. 2004
    ..05). Therefore, it would appear that low leptin concentrations, increased fat oxidation and insulin resistance are associated with increased concentrations of cortisol and interleukin-6 in weight-losing patients with pancreatic cancer...
  8. doi request reprint The mammalian target of rapamycin inhibitor everolimus (RAD001) in early breast cancer: results of a pre-operative study
    E J Macaskill
    Western General Hospital, Edinburgh, EH4 2XU, UK
    Breast Cancer Res Treat 128:725-34. 2011
    ..Tumors with high Ki67, high p-AKT, and HER-2 positivity may be more responsive to mTOR inhibition with RAD001. This is the first study to report results of RAD001 5 mg as a single agent in early breast cancer...
  9. pmc A polymorphism of the interleukin-1 beta gene influences survival in pancreatic cancer
    M D Barber
    University Department of Surgery, Royal Infirmary of Edinburgh, Edinburgh, EH3 9YW, Scotland, UK
    Br J Cancer 83:1443-7. 2000
    ..This may reflect the role of IL-1b in inducing an acute phase protein response and cachexia in cancer or may be related to changes in tumour phenotype...